Acurx Pharmaceuticals Statistics

Total Valuation

ACXP has a market cap or net worth of $8.92 million. The enterprise value is $5.21 million.

Market Cap	8.92M
Enterprise Value	5.21M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ACXP has 22.04 million shares outstanding. The number of shares has increased by 27.56% in one year.

Current Share Class	22.04M
Shares Outstanding	22.04M
Shares Change (YoY)	+27.56%
Shares Change (QoQ)	+3.46%
Owned by Insiders (%)	11.67%
Owned by Institutions (%)	12.18%
Float	19.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	11.20
P/TBV Ratio	14.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.19

Current Ratio	1.19
Quick Ratio	1.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -534.03% and return on invested capital (ROIC) is -333.77%.

Return on Equity (ROE)	-534.03%
Return on Assets (ROA)	-152.41%
Return on Invested Capital (ROIC)	-333.77%
Return on Capital Employed (ROCE)	-2,292.74%
Revenue Per Employee	n/a
Profits Per Employee	-$3.53M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.10% in the last 52 weeks. The beta is -1.35, so ACXP's price volatility has been lower than the market average.

Beta (5Y)	-1.35
52-Week Price Change	-80.10%
50-Day Moving Average	0.49
200-Day Moving Average	1.33
Relative Strength Index (RSI)	49.17
Average Volume (20 Days)	135,543

Short Selling Information

The latest short interest is 418,915, so 1.90% of the outstanding shares have been sold short.

Short Interest	418,915
Short Previous Month	475,579
Short % of Shares Out	1.90%
Short % of Float	2.15%
Short Ratio (days to cover)	2.55

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.10M
Pretax Income	-16.73M
Net Income	-14.10M
EBITDA	n/a
EBIT	-14.10M
Earnings Per Share (EPS)	-$0.87

Full Income Statement

Balance Sheet

The company has $3.71 million in cash and n/a in debt, giving a net cash position of $3.71 million or $0.17 per share.

Cash & Cash Equivalents	3.71M
Total Debt	n/a
Net Cash	3.71M
Net Cash Per Share	$0.17
Equity (Book Value)	615,121
Book Value Per Share	0.04
Working Capital	615,121

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.38M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.56%
Shareholder Yield	n/a
Earnings Yield	-158.13%
FCF Yield	n/a

Analyst Forecast

The average price target for ACXP is $12.00, which is 2,871.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	2,871.03%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.80%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1